Here is why Roche opted for Danish partnership
Swiss-based Roche, one of the international drug companies participating in the so-called Next-partnership, wants to attract more investments to Denmark.
BY STEFAN SINGH KAILAY
The public sector has seen the writing on the wall and wants to make it more attractive for drug companies to invest in clinical research in Denmark.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
“I think they have done a great job”
For abonnenter
Danish region in major deal with Roche
For abonnenter
